FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2098384911> ?p ?o ?g. }

• W2098384911 endingPage "56" @default.
• W2098384911 startingPage "49" @default.
• W2098384911 abstract "Patients with hepatitis B-related decompensated cirrhosis have limited treatment options. This prospective, multicenter study assessed lamivudine in 75 patients with decompensated cirrhosis, the majority of whom (93%) were not candidates for liver transplantation. At baseline, all 75 patients tested positive for hepatitis B surface antigen [HBsAg (+)] and 62% tested positive for hepatitis B e antigen [HBeAg (+)]. Hepatitis B virus (HBV) DNA levels were detectable in 64% of patients by the branched chain DNA (bDNA) assay. Patients received lamivudine 100 mg once daily (median duration, 12.7 months; range, 0.5 to 33 months). In patients with detectable HBV DNA pretreatment, the virus became undetectable by the bDNA assay in 69% of patients with > or = 6 months treatment and in 64% overall. Alanine aminotransferase (ALT) level improved in 90% and normalized in 55% of patients with > or = 6 months treatment and in 48% overall. Improvements in bilirubin and albumin levels occurred throughout treatment. The median Child-Pugh score improved from a baseline of 10 to 8 at last visit, with 31% (23/75) having an improved score of > or = 2 points, 57% (43/75) unchanged (< 2 points), and 12% (9/75) worsened (> or = 2 points). A virologic breakthrough developed in eight of 41 patients (18%) after a median of 13.1 months of treatment. Tyrosine-methionine-aspartate-aspartate (YMDD) variant HBV was detected in three of four patients tested. Nevertheless, at last visit, ALT, albumin, and bilirubin levels were similar for patients with and without breakthrough. Lamivudine treatment can lead to significant improvements in liver disease severity in nontransplantation candidates with advanced disease. Additional studies of lamivudine in combination with other antivirals are indicated for the large population of patients worldwide with advanced HBV-related cirrhosis and inadequate access to liver transplantation." @default.
• W2098384911 created "2016-06-24" @default.
• W2098384911 creator A5000208156 @default.
• W2098384911 creator A5009050197 @default.
• W2098384911 creator A5027113198 @default.
• W2098384911 creator A5030460373 @default.
• W2098384911 creator A5032083984 @default.
• W2098384911 creator A5035891277 @default.
• W2098384911 creator A5043581009 @default.
• W2098384911 creator A5053286153 @default.
• W2098384911 creator A5056557259 @default.
• W2098384911 creator A5063597784 @default.
• W2098384911 creator A5066434209 @default.
• W2098384911 date "2003-01-01" @default.
• W2098384911 modified "2023-09-26" @default.
• W2098384911 title "A United States compassionate use study of lamivudine treatment in nontransplantation candidates with decompensated hepatitis B virus–related cirrhosis" @default.
• W2098384911 cites W1498132922 @default.
• W2098384911 cites W1581230849 @default.
• W2098384911 cites W1647175450 @default.
• W2098384911 cites W1960579853 @default.
• W2098384911 cites W1995468190 @default.
• W2098384911 cites W1999263104 @default.
• W2098384911 cites W2001578477 @default.
• W2098384911 cites W2003709460 @default.
• W2098384911 cites W2010235149 @default.
• W2098384911 cites W2025070284 @default.
• W2098384911 cites W2029262242 @default.
• W2098384911 cites W2044553804 @default.
• W2098384911 cites W2049604384 @default.
• W2098384911 cites W2068473222 @default.
• W2098384911 cites W2071212887 @default.
• W2098384911 cites W2071904124 @default.
• W2098384911 cites W2074433769 @default.
• W2098384911 cites W2074617575 @default.
• W2098384911 cites W2078970044 @default.
• W2098384911 cites W2084720260 @default.
• W2098384911 cites W2085990351 @default.
• W2098384911 cites W2096808350 @default.
• W2098384911 cites W2109316484 @default.
• W2098384911 cites W2124012164 @default.
• W2098384911 cites W2147292430 @default.
• W2098384911 cites W2149836081 @default.
• W2098384911 cites W2154487736 @default.
• W2098384911 cites W2158084983 @default.
• W2098384911 cites W2159639664 @default.
• W2098384911 cites W2293495463 @default.
• W2098384911 cites W2332715695 @default.
• W2098384911 cites W2338794667 @default.
• W2098384911 cites W3152231134 @default.
• W2098384911 cites W4362208329 @default.
• W2098384911 doi "https://doi.org/10.1053/jlts.2003.50005" @default.
• W2098384911 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12514773" @default.
• W2098384911 hasPublicationYear "2003" @default.
• W2098384911 type Work @default.
• W2098384911 sameAs 2098384911 @default.
• W2098384911 citedByCount "61" @default.
• W2098384911 countsByYear W20983849112012 @default.
• W2098384911 countsByYear W20983849112013 @default.
• W2098384911 countsByYear W20983849112014 @default.
• W2098384911 countsByYear W20983849112015 @default.
• W2098384911 countsByYear W20983849112016 @default.
• W2098384911 countsByYear W20983849112017 @default.
• W2098384911 countsByYear W20983849112019 @default.
• W2098384911 countsByYear W20983849112020 @default.
• W2098384911 crossrefType "journal-article" @default.
• W2098384911 hasAuthorship W2098384911A5000208156 @default.
• W2098384911 hasAuthorship W2098384911A5009050197 @default.
• W2098384911 hasAuthorship W2098384911A5027113198 @default.
• W2098384911 hasAuthorship W2098384911A5030460373 @default.
• W2098384911 hasAuthorship W2098384911A5032083984 @default.
• W2098384911 hasAuthorship W2098384911A5035891277 @default.
• W2098384911 hasAuthorship W2098384911A5043581009 @default.
• W2098384911 hasAuthorship W2098384911A5053286153 @default.
• W2098384911 hasAuthorship W2098384911A5056557259 @default.
• W2098384911 hasAuthorship W2098384911A5063597784 @default.
• W2098384911 hasAuthorship W2098384911A5066434209 @default.
• W2098384911 hasBestOaLocation W20983849111 @default.
• W2098384911 hasConcept C126322002 @default.
• W2098384911 hasConcept C151678543 @default.
• W2098384911 hasConcept C203014093 @default.
• W2098384911 hasConcept C2522874641 @default.
• W2098384911 hasConcept C2775940106 @default.
• W2098384911 hasConcept C2776408679 @default.
• W2098384911 hasConcept C2777075537 @default.
• W2098384911 hasConcept C2777214474 @default.
• W2098384911 hasConcept C2777382497 @default.
• W2098384911 hasConcept C2777410769 @default.
• W2098384911 hasConcept C2777513400 @default.
• W2098384911 hasConcept C2777869810 @default.
• W2098384911 hasConcept C2779609443 @default.
• W2098384911 hasConcept C2780593183 @default.
• W2098384911 hasConcept C2911091166 @default.
• W2098384911 hasConcept C71924100 @default.
• W2098384911 hasConcept C90924648 @default.
• W2098384911 hasConceptScore W2098384911C126322002 @default.
• W2098384911 hasConceptScore W2098384911C151678543 @default.
• W2098384911 hasConceptScore W2098384911C203014093 @default.
• W2098384911 hasConceptScore W2098384911C2522874641 @default.

• next